Diabetes :: Cymbalta reduces night pain in patients with diabetic nerve pain

Data from a pooled analysis of three studies suggest that in patients with pain caused by diabetic nerve damage, or diabetic peripheral neuropathy, who are treated with Cymbalta (duloxetine HCl), improvements in both average daily pain and night pain severity were associated with less pain-related sleep interference than in those patients taking sugar pill.

Diet :: Research team sheds light on diet of early human ancestors

Eight years ago, the field of anthropology was rocked by isotopic evidence that suggested one-third of the diet of early human ancestors consisted of grasses and sedges, or the tissue of animals that ate such plants. The news puzzled scientists, who were unable to reconcile the results with what they knew about the teeth of human ancestors who lived more than 2 million years ago.

Parkinson’s Disease :: Link between Parkinson’s disease and Narcolepsy

Parkinson’s disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking. Less well known is that Parkinson’s shares other symptoms with narcolepsy, a sleep disorder characterized by sudden and uncontrollable episodes of deep sleep, severe fatigue and general sleep disorder.

NHS :: Quality assurance and performance management in obstetric practice

Obstetrics is a high risk specialty with high negligence claims payments in the NHS. The introduction of the European Working Time Directive (EWTD) and the breakdown of the traditional ?firm? structure has meant that contact time between consultants and their trainees is falling, and young doctors run the risk of losing valuable experience gained from being mentored by senior staff.

Stem Cell :: Human embryonic stem cells to achieve vascular repair

Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time that hemangioblast precursor cells derived from human embryonic stem (hES) cells can be used to achieve vascular repair. The research, which appears today online (ahead of print) in the journal Nature Methods, by Advanced Cell Technology (ACT) and its collaborators, describes an efficient method for generating large numbers of bipotential progenitors–known as hemangioblasts–from hES cells that are capable of differentiating into blood vessels, as well as into all blood and immune cell lineages.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack